For the Inventor, By the Inventor

Enter assignee name

Biolinerx Ltd.

USPTO Granted Patents = 19

CIPO Patents = 3

EPO Patents = 6

Trademarks = 4

Forward Citations = 32

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Amnon Peled (16 out of 37 patents)

Yaron Pereg (13 out of 14 patents)

Efrat Halbfinger (4 out of 5 patents)

4. Ella Sorani (3 out of 3 patents)

5. Ada Rephaeli (2 out of 15 patents)

6. Irit Gil-Ad (2 out of 15 patents)

7. Abraham Weizman (2 out of 13 patents)

8. Abraham Nudelman (2 out of 45 patents)

9. Osnat Bohana-Kashtan (1 out of 7 patents)

10. Mazal Shaul (1 out of 2 patents)

11. Ran Lifshitz (1 out of 1 patent)

12. Ilan Winkler (1 out of 1 patent)

13. Abi Vainstein-haras (1 out of 1 patent)

14. Irit Gliko-Kabir (1 out of 1 patent)

15. Michal Abraham (8 patents)

19 patents: Sort by Forward Citations

1. 12291570 - Treatment of metastatic pancreatic adenocarcinoma (2025-05-06),

2. 12268725 - Composition of BL-8040 (2025-04-08),

3. 12257285 - Composition of BL-8040 (2025-03-25),

4. 11993631 - Process for manufacturing peptide (2024-05-28),

5. 11648293 - Compositions and methods for treating cancer (2023-05-16),

6. 11642393 - Compositions and methods for treating cancer (2023-05-09),

7. 11638743 - Compositions and methods for treating cancer (2023-05-02),

8. 11638742 - Compositions and methods for treating cancer (2023-05-02),

9. 11612638 - Compositions and methods for treating cancer (2023-03-28),

10. 11607444 - Compositions and methods for treating cancer (2023-03-21),

11. 11596666 - Compositions and methods for treating cancer (2023-03-07),

12. 11590200 - Compositions and methods for treating cancer (2023-02-28),

13. 11559562 - Compositions and methods for treating cancer (2023-01-24),

14. 11554159 - Compositions and methods for treating cancer (2023-01-17),

15. 11534478 - Compositions and methods for treating cancer (2022-12-27),

BioLineRx Ltd. is a clinical-stage biopharmaceutical company focused on oncology, immunology, and other therapeutic areas. They are dedicated to developing novel drugs to address unmet medical needs and improve patient outcomes. BioLineRx emphasizes a comprehensive approach, from early-stage research to advanced clinical trials and partnerships with leading academic and pharmaceutical institutions. Through innovative science and strategic collaborations, BioLineRx aims to bring breakthrough therapies to patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

19 Patents

#2 in Modiin

#304 in Israel

#31,670 in the World

Biolinerx Ltd.

Forward Citations = 32

21 inventors:

Amnon Peled (16 out of 37 patents)

Yaron Pereg (13 out of 14 patents)

Efrat Halbfinger (4 out of 5 patents)

4. Ella Sorani (3 out of 3 patents)

5. Ada Rephaeli (2 out of 15 patents)

Please report any incorrect information to support@idiyas.com

Loading…